Funding for TB and Neglected Disease Research Must Increase to Realize Promise of New Technologies
Statement from TB Alliance on release of the G-FINDER 2024 Neglected Disease R&D Report NEW YORK (January 29, 2025)—The G-FINDER 2024 Neglected
Statement from TB Alliance on release of the G-FINDER 2024 Neglected Disease R&D Report NEW YORK (January 29, 2025)—The G-FINDER 2024 Neglected
BALI, Indonesia (November 11, 2024)—TB Alliance is honored to join today’s High-Level Meeting hosted by the Indonesian Ministry of Health.
NEW YORK (August 21, 2024) – In July 2024, a Phase 2 proof-of-concept study was initiated to explore the use
MANILA (25 March 2024)—TB Alliance’s new Peer-to-Peer Learning for Innovative Cures (PeerLINC) Knowledge Hub launched today in Manila, with funding
NEW YORK (March 24, 2024)—Today is World TB Day, the anniversary of when, in 1882, Dr. Robert Koch announced his
The 2023 United Nations (UN) High-Level Meeting (HLM) on Tuberculosis (TB) saw world leaders come together to commit to increased
TB Alliance wholeheartedly supports the commitment made today at the United Nations High-Level Meeting on Tuberculosis (TB) to fight this
Four years ago, TB Alliance secured the first regulatory approval from the United States Food and Drug Administration (US FDA)
19 December 2022: Viatris, a global healthcare company, MedAccess, and TB Alliance have announced a new agreement to reduce the
PRETORIA (16 November, 2022)—A new study published in PLOS Global Public Health found that the BPaLM/BPaL treatment regimen that will